Literature DB >> 22177847

Galectin-9 signaling prolongs survival in murine lung-cancer by inducing macrophages to differentiate into plasmacytoid dendritic cell-like macrophages.

Takeshi Kadowaki1, Tomohiro Arikawa, Rika Shinonaga, Souichi Oomizu, Hiroyuki Inagawa, Genichiro Soma, Toshiro Niki, Mitsuomi Hirashima.   

Abstract

Galectin-9 (Gal-9) expanded plasmacytoid dendritic cell-like macrophages (pDC-Mϕs) in lung cancer-bearing mice and prolonged the survival. Gal-9 increased the frequency of CD11c(high) cells in M-CSF- but not GM-CSF-induced Mϕs in vitro in a Tim-3 independent manner. CD11c(high) cells differentiated with M-CSF+Gal-9 expressed pDC-Mϕ markers, such as PDCA-1 and F4/80. These cells expressed high TLR7, TLR8 and TLR9, although they exhibited decreased IFN-α mRNA levels. LPS or LLC stimulation further elevated pDC-Mϕ markers, indicating that M-CSF+Gal-9-induced Mϕs were pDC-Mϕ precursors. Moreover, LPS stimulation resulted in the increased IRF7 and E2-2 levels, suggesting that the pDC-Mϕ precursors matured into pDC-Mϕs. These matured pDC-Mϕs augmented NK cell-mediated cytotoxicity though they did not produce IFN-α upon TLR7 or TLR9 stimulation. The present results suggest that Gal-9 induces Mϕs to differentiate to pDC-Mϕs, and that this switch in differentiation favors the activation of NK cells that are able to prolong the survival of tumor-bearing mice. Copyright Â
© 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22177847     DOI: 10.1016/j.clim.2011.11.006

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  18 in total

1.  Increased Tim-3 expression alleviates liver injury by regulating macrophage activation in MCD-induced NASH mice.

Authors:  Xianhong Du; Zhuanchang Wu; Yong Xu; Yuan Liu; Wen Liu; Tixiao Wang; Chunyang Li; Cuijuan Zhang; Fan Yi; Lifen Gao; Xiaohong Liang; Chunhong Ma
Journal:  Cell Mol Immunol       Date:  2018-05-07       Impact factor: 11.530

Review 2.  The emerging role of galectins in high-fatality cancers.

Authors:  Cherylane Dubé-Delarosbil; Yves St-Pierre
Journal:  Cell Mol Life Sci       Date:  2017-11-08       Impact factor: 9.261

3.  Galectin-9 functionally impairs natural killer cells in humans and mice.

Authors:  Lucy Golden-Mason; Rachel H McMahan; Michael Strong; Richard Reisdorph; Spencer Mahaffey; Brent E Palmer; Linling Cheng; Caroline Kulesza; Mitsuomi Hirashima; Toshiro Niki; Hugo R Rosen
Journal:  J Virol       Date:  2013-02-13       Impact factor: 5.103

4.  Cell surface galectin-9 expressing Th cells regulate Th17 and Foxp3+ Treg development by galectin-9 secretion.

Authors:  Souichi Oomizu; Tomohiro Arikawa; Toshiro Niki; Takeshi Kadowaki; Masaki Ueno; Nozomu Nishi; Akira Yamauchi; Toshio Hattori; Tsutomu Masaki; Mitsuomi Hirashima
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

5.  Decreased galectin-9 and increased Tim-3 expression are related to poor prognosis in gastric cancer.

Authors:  Jing Jiang; Mei-Shan Jin; Fei Kong; Donghui Cao; Hong-Xi Ma; Zhifang Jia; Yin-Ping Wang; Jian Suo; Xueyuan Cao
Journal:  PLoS One       Date:  2013-12-10       Impact factor: 3.240

Review 6.  Tim-3: an activation marker and activation limiter of innate immune cells.

Authors:  Gencheng Han; Guojiang Chen; Beifen Shen; Yan Li
Journal:  Front Immunol       Date:  2013-12-10       Impact factor: 7.561

7.  The role of TIM-containing molecules in airway disease and their potential as therapeutic targets.

Authors:  Isabel Vega-Carrascal; Emer P Reeves; Noel G McElvaney
Journal:  J Inflamm Res       Date:  2012-08-14

8.  Galectin-9 ameliorates clinical severity of MRL/lpr lupus-prone mice by inducing plasma cell apoptosis independently of Tim-3.

Authors:  Masahiro Moritoki; Takeshi Kadowaki; Toshiro Niki; Daisuke Nakano; Genichiro Soma; Hirohito Mori; Hideki Kobara; Tsutomu Masaki; Masakazu Kohno; Mitsuomi Hirashima
Journal:  PLoS One       Date:  2013-04-09       Impact factor: 3.240

9.  Galectin-9 prolongs the survival of septic mice by expanding Tim-3-expressing natural killer T cells and PDCA-1+ CD11c+ macrophages.

Authors:  Takashi Kadowaki; Asahiro Morishita; Toshiro Niki; Junko Hara; Miwa Sato; Joji Tani; Hisaaki Miyoshi; Hirohito Yoneyama; Tsutomu Masaki; Toshio Hattori; Akihiro Matsukawa; Mitsuomi Hirashima
Journal:  Crit Care       Date:  2013-12-09       Impact factor: 9.097

10.  Reduced Expression of Galectin-9 Contributes to a Poor Outcome in Colon Cancer by Inhibiting NK Cell Chemotaxis Partially through the Rho/ROCK1 Signaling Pathway.

Authors:  Yang Wang; Jintang Sun; Chao Ma; Wenjuan Gao; Bingfeng Song; Hao Xue; Weiliang Chen; Xi Chen; Yun Zhang; Qianqian Shao; Qingjie Wang; Lei Zhao; Jia Liu; Xiuwen Wang; Huayang Wang; Yun Zhang; Meixiang Yang; Xun Qu
Journal:  PLoS One       Date:  2016-03-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.